1. Home
  2. ALDX vs RIV Comparison

ALDX vs RIV Comparison

Compare ALDX & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • RIV
  • Stock Information
  • Founded
  • ALDX 2004
  • RIV 2015
  • Country
  • ALDX United States
  • RIV United States
  • Employees
  • ALDX N/A
  • RIV N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • RIV Finance Companies
  • Sector
  • ALDX Health Care
  • RIV Finance
  • Exchange
  • ALDX Nasdaq
  • RIV Nasdaq
  • Market Cap
  • ALDX 319.4M
  • RIV 267.3M
  • IPO Year
  • ALDX 2014
  • RIV N/A
  • Fundamental
  • Price
  • ALDX $4.85
  • RIV $12.35
  • Analyst Decision
  • ALDX Strong Buy
  • RIV
  • Analyst Count
  • ALDX 2
  • RIV 0
  • Target Price
  • ALDX $10.00
  • RIV N/A
  • AVG Volume (30 Days)
  • ALDX 571.6K
  • RIV 87.6K
  • Earning Date
  • ALDX 11-07-2024
  • RIV 01-01-0001
  • Dividend Yield
  • ALDX N/A
  • RIV 12.85%
  • EPS Growth
  • ALDX N/A
  • RIV N/A
  • EPS
  • ALDX N/A
  • RIV N/A
  • Revenue
  • ALDX N/A
  • RIV N/A
  • Revenue This Year
  • ALDX N/A
  • RIV N/A
  • Revenue Next Year
  • ALDX $25.36
  • RIV N/A
  • P/E Ratio
  • ALDX N/A
  • RIV N/A
  • Revenue Growth
  • ALDX N/A
  • RIV N/A
  • 52 Week Low
  • ALDX $2.43
  • RIV $9.63
  • 52 Week High
  • ALDX $6.55
  • RIV $12.43
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 45.59
  • RIV 39.95
  • Support Level
  • ALDX $4.66
  • RIV $12.31
  • Resistance Level
  • ALDX $5.01
  • RIV $12.50
  • Average True Range (ATR)
  • ALDX 0.40
  • RIV 0.16
  • MACD
  • ALDX -0.01
  • RIV -0.01
  • Stochastic Oscillator
  • ALDX 46.06
  • RIV 8.37

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

About RIV RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.

Share on Social Networks: